137 related articles for article (PubMed ID: 11140735)
1. Synthesis and biological activity of the 1alpha,25-dihydroxyvitamin D3 diastereomer with unnatural configuration at the rings C/D side-chain moiety.
Marczak S; Przezdziecka A; Wicha J; Steinmeyer A; Zügel U
Bioorg Med Chem Lett; 2001 Jan; 11(1):63-6. PubMed ID: 11140735
[TBL] [Abstract][Full Text] [Related]
2. New C15-substituted active vitamin D3.
Shindo K; Kumagai G; Takano M; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Ishizuka S; Takenouchi K; Kittaka A
Org Lett; 2011 Jun; 13(11):2852-5. PubMed ID: 21539305
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3.
Sicinski RR; DeLuca HF
Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluations of A-ring isomers of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Ikeda M; Takahashi K; Dan A; Koyama K; Kubota K; Tanaka T; Hayashi M
Bioorg Med Chem; 2000 Aug; 8(8):2157-66. PubMed ID: 11003160
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new aromatic (C17-C20)-locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D(3)).
Fernández-Gacio A; Vitale C; Mouriño A
J Org Chem; 2000 Oct; 65(21):6978-83. PubMed ID: 11031019
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of a 1 alpha,25-dihydroxyvitamin D3 dimer as a potential chemical inducer of vitamin D receptor dimerization.
Pérez Sestelo J; Mouriño A; Sarandeses LA
Org Lett; 1999 Oct; 1(7):1005-7. PubMed ID: 10825953
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
Zhou X; Zhu GD; Van Haver D; Vandewalle M; De Clercq PJ; Verstuyf A; Bouillon R
J Med Chem; 1999 Sep; 42(18):3539-56. PubMed ID: 10479287
[TBL] [Abstract][Full Text] [Related]
8. Functionalization at C-12 of 1alpha,25-dihydroxyvitamin D(3) strongly modulates the affinity for the vitamin D receptor (VDR).
González-Avión XC; Mouriño A
Org Lett; 2003 Jun; 5(13):2291-3. PubMed ID: 12816431
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT).
Hatakeyama S; Okano T; Maeyama J; Esumi T; Hiyamizu H; Iwabuchi Y; Nakagawa K; Ozono K; Kawase A; Kubodera N
Bioorg Med Chem; 2001 Feb; 9(2):403-15. PubMed ID: 11249133
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
[TBL] [Abstract][Full Text] [Related]
11. Total synthesis of 1α,25-dihydroxyvitamin D
López-Pérez B; Maestro MA; Mouriño A
Org Biomol Chem; 2018 Jun; 16(24):4563-4569. PubMed ID: 29881848
[TBL] [Abstract][Full Text] [Related]
12. A concise and efficient route to 2alpha-(omega-hydroxyalkoxy)-1alpha,25-dihydroxyvi tam in D3: remarkably high affinity to vitamin D receptor.
Kittaka A; Suhara Y; Takayanagi H; Fujishima T; Kurihara M; Takayama H
Org Lett; 2000 Aug; 2(17):2619-22. PubMed ID: 10990411
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric catalytic ene-cyclization approach to 2-fluoro-19-nor-1,25-dihydroxyvitamin D(3) A-ring analog with significant transactivation activity.
Mikami K; Ohba S; Ohmura H; Kubodera N; Nakagawa K; Okano T
Chirality; 2001 Jul; 13(7):366-71. PubMed ID: 11400190
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3.
Fujishima T; Liu Z; Miura D; Chokki M; Ishizuka S; Konno K; Takayama H
Bioorg Med Chem Lett; 1998 Aug; 8(16):2145-8. PubMed ID: 9873502
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
Verlinden L; Verstuyf A; Eelen G; Bouillon R; Ordóñez-Morán P; Larriba MJ; Muñoz A; Rochel N; Sato Y; Moras D; Maestro M; Seoane S; Dominguez F; Eduardo-Canosa S; Nicoletti D; Moman E; Mouriño A
ChemMedChem; 2011 May; 6(5):788-93. PubMed ID: 21520419
[TBL] [Abstract][Full Text] [Related]
16. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and biological evaluation of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
Suhara Y; Nihei KI; Tanigawa H; Fujishima T; Konno K; Nakagawa K; Okano T; Takayama H
Bioorg Med Chem Lett; 2000 May; 10(10):1129-32. PubMed ID: 10843234
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators.
Fujishima T; Kittaka A; Yamaoka K; Takeyama K; Kato S; Takayama H
Org Biomol Chem; 2003 Jun; 1(11):1863-9. PubMed ID: 12945766
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
[TBL] [Abstract][Full Text] [Related]
20. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
